[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Alzheimer Drug Market 2023 by Company, Regions, Type and Application, Forecast to 2029

February 2023 | 60 pages | ID: GEEE097C1387EN
GlobalInfoResearch

US$ 3,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The Alzheimer Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Alzheimer Drug market size will reach USD million in 2029, growing at a CAGR of % over the analysis period.

Market segmentation

Alzheimer Drug market is split by Type and by Application. For the period 2023-2029, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
  • Aducanumab
  • Donepezil
  • Rivastigmine
  • Memantine
  • Others
Market segment by Application, can be divided into
  • Mild Alzheimer
  • Moderate Alzheimer
  • Severe Alzheimer
Market segment by players, this report covers
  • Biogen
  • Eli Lilly
  • Alzheon
Market segment by regions, regional analysis covers
  • North America
  • Europe
  • Asia-Pacific (China, Japan, South Korea, Rest of Asia-Pacific)
  • South America
  • Middle East & Africa
The content of the study subjects, includes a total of 8 chapters:

Chapter 1, to describe Alzheimer Drug product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top players of Alzheimer Drug, with recent developments and future plans

Chapter 3, the Alzheimer Drug competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4, to break the market size data at the region level, with key companies in the key region and Alzheimer Drug market forecast, by regions, with revenue, from 2023 to 2029.

Chapter 5 and 6, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2023 to 2029.

Chapter 7 and 8, to describe Alzheimer Drug research findings and conclusion, appendix and data source.
1 MARKET OVERVIEW

1.1 Product Overview and Scope of Alzheimer Drug
1.2 Classification of Alzheimer Drug by Type
  1.2.1 Overview: Global Alzheimer Drug Market Size by Type: 2022 Versus 2028
  1.2.2 Global Alzheimer Drug Revenue Market Share by Type in 2029
  1.2.3 Aducanumab
  1.2.4 Donepezil
  1.2.5 Rivastigmine
  1.2.6 Memantine
  1.2.7 Others
1.3 Global Alzheimer Drug Market by Application
  1.3.1 Overview: Global Alzheimer Drug Market Size by Application: 2023 Versus 2029
  1.3.2 Mild Alzheimer
  1.3.3 Moderate Alzheimer
  1.3.4 Severe Alzheimer
1.4 Global Alzheimer Drug Market Size & Forecast
1.5 Market Drivers, Restraints and Trends
  1.5.1 Alzheimer Drug Market Drivers
  1.5.2 Alzheimer Drug Market Restraints
  1.5.3 Alzheimer Drug Trends Analysis

2 COMPANY PROFILES

2.1 Biogen
  2.1.1 Biogen Details
  2.1.2 Biogen Major Business
  2.1.3 Biogen Alzheimer Drug Product and Solutions
  2.1.4 Biogen Recent Developments and Future Plans
2.2 Eli Lilly
  2.2.1 Eli Lilly Details
  2.2.2 Eli Lilly Major Business
  2.2.3 Eli Lilly Alzheimer Drug Product and Solutions
  2.2.4 Eli Lilly Recent Developments and Future Plans
2.3 Alzheon
  2.3.1 Alzheon Details
  2.3.2 Alzheon Major Business
  2.3.3 Alzheon Alzheimer Drug Product and Solutions
  2.3.4 Alzheon Recent Developments and Future Plans

3 MARKET COMPETITION, BY PLAYERS

3.1 Global Alzheimer Drug Revenue and Share by Players (2023 & 2029)
3.2 Alzheimer Drug Players Head Office, Products and Services Provided
3.3 Alzheimer Drug Mergers & Acquisitions
3.4 Alzheimer Drug New Entrants and Expansion Plans

4 GLOBAL ALZHEIMER DRUG FORECAST BY REGION

4.1 Global Alzheimer Drug Market Size by Region: 2023 VS 2029
4.2 Global Alzheimer Drug Market Size by Region, (2023-2029)
4.3 North America
  4.3.1 Key Companies of Alzheimer Drug in North America
  4.3.2 Current Situation and Forecast of Alzheimer Drug in North America
  4.3.3 North America Alzheimer Drug Market Size and Prospect (2023-2029)
4.4 Europe
  4.4.1 Key Companies of Alzheimer Drug in Europe
  4.4.2 Current Situation and Forecast of Alzheimer Drug in Europe
  4.4.3 Europe Alzheimer Drug Market Size and Prospect (2023-2029)
4.5 Asia-Pacific
  4.5.1 Key Companies of Alzheimer Drug in Asia-Pacific
  4.5.2 Current Situation and Forecast of Alzheimer Drug in Asia-Pacific
  4.5.3 Asia-Pacific Alzheimer Drug Market Size and Prospect (2023-2029)
  4.5.4 China
  4.5.5 Japan
  4.5.6 South Korea
4.6 South America
  4.6.1 Key Companies of Alzheimer Drug in South America
  4.6.2 Current Situation and Forecast of Alzheimer Drug in South America
  4.6.3 South America Alzheimer Drug Market Size and Prospect (2023-2029)
4.7 Middle East & Africa
  4.7.1 Key Companies of Alzheimer Drug in Middle East & Africa
  4.7.2 Current Situation and Forecast of Alzheimer Drug in Middle East & Africa
  4.7.3 Middle East & Africa Alzheimer Drug Market Size and Prospect (2023-2029)

5 MARKET SIZE SEGMENT BY TYPE

5.1 Global Alzheimer Drug Market Forecast by Type (2023-2029)
5.2 Global Alzheimer Drug Market Share Forecast by Type (2023-2029)

6 MARKET SIZE SEGMENT BY APPLICATION

6.1 Global Alzheimer Drug Market Forecast by Application (2023-2029)
6.2 Global Alzheimer Drug Market Share Forecast by Application (2023-2029)

7 RESEARCH FINDINGS AND CONCLUSION

8 APPENDIX

8.1 Methodology
8.2 Research Process and Data Source
8.3 Disclaimer

LIST OF TABLES

Table 1. Global Alzheimer Drug Revenue by Type, (USD Million), 2023 VS 2029
Table 2. Global Alzheimer Drug Revenue by Application, (USD Million), 2023 VS 2029
Table 3. Biogen Corporate Information, Head Office, and Major Competitors
Table 4. Biogen Major Business
Table 5. Biogen Alzheimer Drug Product and Solutions
Table 6. Eli Lilly Corporate Information, Head Office, and Major Competitors
Table 7. Eli Lilly Major Business
Table 8. Eli Lilly Alzheimer Drug Product and Solutions
Table 9. Alzheon Corporate Information, Head Office, and Major Competitors
Table 10. Alzheon Major Business
Table 11. Alzheon Alzheimer Drug Product and Solutions
Table 12. Global Alzheimer Drug Revenue (USD Million) by Players (2023 & 2029)
Table 13. Global Alzheimer Drug Revenue Share by Players (2023 & 2029)
Table 14. Alzheimer Drug Players Head Office, Products and Services Provided
Table 15. Alzheimer Drug Mergers & Acquisitions in the Past Five Years
Table 16. Alzheimer Drug New Entrants and Expansion Plans
Table 17. Global Market Alzheimer Drug Revenue (USD Million) Comparison by Region (2023 VS 2029)
Table 18. Global Alzheimer Drug Revenue Market Share by Region (2023-2029)
Table 19. Key Companies of Alzheimer Drug in North America
Table 20. Current Situation and Forecast of Alzheimer Drug in North America
Table 21. Key Companies of Alzheimer Drug in Europe
Table 22. Current Situation and Forecast of Alzheimer Drug in Europe
Table 23. Key Companies of Alzheimer Drug in Asia-Pacific
Table 24. Current Situation and Forecast of Alzheimer Drug in Asia-Pacific
Table 25. Key Companies of Alzheimer Drug in China
Table 26. Key Companies of Alzheimer Drug in Japan
Table 27. Key Companies of Alzheimer Drug in South Korea
Table 28. Key Companies of Alzheimer Drug in South America
Table 29. Current Situation and Forecast of Alzheimer Drug in South America
Table 30. Key Companies of Alzheimer Drug in Middle East & Africa
Table 31. Current Situation and Forecast of Alzheimer Drug in Middle East & Africa
Table 32. Global Alzheimer Drug Revenue Forecast by Type (2023-2029)
Table 33. Global Alzheimer Drug Revenue Forecast by Application (2023-2029)

LIST OF FIGURES

Figure 1. Alzheimer Drug Picture
Figure 2. Global Alzheimer Drug Revenue Market Share by Type in 2029
Figure 3. Aducanumab
Figure 4. Donepezil
Figure 5. Rivastigmine
Figure 6. Memantine
Figure 7. Others
Figure 8. Alzheimer Drug Revenue Market Share by Application in 2029
Figure 9. Mild Alzheimer Picture
Figure 10. Moderate Alzheimer Picture
Figure 11. Severe Alzheimer Picture
Figure 12. Global Alzheimer Drug Market Size, (USD Million): 2023 VS 2029
Figure 13. Global Alzheimer Drug Revenue and Forecast (2023-2029) & (USD Million)
Figure 14. Alzheimer Drug Market Drivers
Figure 15. Alzheimer Drug Market Restraints
Figure 16. Alzheimer Drug Market Trends
Figure 17. Biogen Recent Developments and Future Plans
Figure 18. Eli Lilly Recent Developments and Future Plans
Figure 19. Alzheon Recent Developments and Future Plans
Figure 20. Global Alzheimer Drug Revenue Market Share by Region (2023-2029)
Figure 21. Global Alzheimer Drug Revenue Market Share by Region in 2029
Figure 22. North America Alzheimer Drug Revenue (USD Million) and Growth Rate (2023-2029)
Figure 23. Europe Alzheimer Drug Revenue (USD Million) and Growth Rate (2023-2029)
Figure 24. Asia-Pacific Alzheimer Drug Revenue (USD Million) and Growth Rate (2023-2029)
Figure 25. South America Alzheimer Drug Revenue (USD Million) and Growth Rate (2023-2029)
Figure 26. Middle East & Africa Alzheimer Drug Revenue (USD Million) and Growth Rate (2023-2029)
Figure 27. Global Alzheimer Drug Market Share Forecast by Type (2023-2029)
Figure 28. Global Alzheimer Drug Market Share Forecast by Application (2023-2029)
Figure 29. Methodology
Figure 30. Research Process and Data Source


More Publications